These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 27327448)
21. Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review. Melek J; Sakuraba A Clin Gastroenterol Hepatol; 2014 Jan; 12(1):32-44.e5. PubMed ID: 23981521 [TBL] [Abstract][Full Text] [Related]
22. Prevalence and risk factors for nonvertebral bone fractures in kidney transplant recipients - a single-center retrospective analysis. Jerman A; Lindič J; Škoberne A; Borštnar Š; Martinuč Bergoč M; Godnov U; Kovač D Clin Nephrol; 2017 Supplement 1; 88(13):101-108. PubMed ID: 28655391 [TBL] [Abstract][Full Text] [Related]
23. Effects of bisphosphonates on long-term kidney transplantation outcomes. Song SH; Choi HY; Kim HY; Nam CM; Jeong HJ; Kim MS; Kim SII; Kim YS; Huh KH; Kim BS Nephrol Dial Transplant; 2021 Mar; 36(4):722-729. PubMed ID: 33367861 [TBL] [Abstract][Full Text] [Related]
24. Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday. Xu LH; Adams-Huet B; Poindexter JR; Maalouf NM Osteoporos Int; 2016 May; 27(5):1701-8. PubMed ID: 26642963 [TBL] [Abstract][Full Text] [Related]
25. Bisphosphonates for preventing bone disease in kidney transplant recipients: a meta-analysis of randomized controlled trials. Versele EB; Van Laecke S; Dhondt AW; Verbeke F; Vanholder R; Van Biesen W; Nagler EV Transpl Int; 2016 Feb; 29(2):153-64. PubMed ID: 26369899 [TBL] [Abstract][Full Text] [Related]
26. Evaluation and management of bone disease and fractures post transplant. Bia M Transplant Rev (Orlando); 2008 Jan; 22(1):52-61. PubMed ID: 18631858 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and Safety of Bisphosphonates for Osteoporosis or Osteopenia in Cardiac Transplant Patients: A Meta-Analysis. Zhao J; Wang C; Hu Z Transplant Proc; 2015 Dec; 47(10):2957-64. PubMed ID: 26707321 [TBL] [Abstract][Full Text] [Related]
28. Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation. Haas M; Leko-Mohr Z; Roschger P; Kletzmayr J; Schwarz C; Mitterbauer C; Steininger R; Grampp S; Klaushofer K; Delling G; Oberbauer R Kidney Int; 2003 Mar; 63(3):1130-6. PubMed ID: 12631097 [TBL] [Abstract][Full Text] [Related]
29. Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trial. Sugimoto T; Shiraki M; Nakano T; Kishimoto H; Ito M; Fukunaga M; Hagino H; Sone T; Kuroda T; Nakamura T Curr Med Res Opin; 2013 Mar; 29(3):195-203. PubMed ID: 23259702 [TBL] [Abstract][Full Text] [Related]
30. Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis. Beaudoin C; Jean S; Bessette L; Ste-Marie LG; Moore L; Brown JP Osteoporos Int; 2016 Sep; 27(9):2835-2844. PubMed ID: 27120345 [TBL] [Abstract][Full Text] [Related]
31. Impact of vitamin D, bisphosphonate, and combination therapy on bone mineral density in kidney transplant patients. Jeon HJ; Han M; Jeong JC; Kim YJ; Kwon HY; Koo TY; Ahn C; Yang J Transplant Proc; 2013 Oct; 45(8):2963-7. PubMed ID: 24157013 [TBL] [Abstract][Full Text] [Related]
32. Oral bisphosphonate treatment for osteogenesis imperfecta--an Indian perspective. Shah I; Johari A Ann Trop Paediatr; 2007 Mar; 27(1):39-43. PubMed ID: 17469731 [TBL] [Abstract][Full Text] [Related]
33. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation. Dodidou P; Bruckner T; Hosch S; Haass M; Klar E; Sauer P; Ziegler R; Leidig-Bruckner G Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of medications for osteoporosis in kidney transplant recipients or patients with chronic kidney disease: A meta-analysis. Leng Y; Yu X; Yang Y; Xia Y J Investig Med; 2023 Oct; 71(7):760-772. PubMed ID: 37387531 [TBL] [Abstract][Full Text] [Related]
36. Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism. Roe SD; Porter CJ; Godber IM; Hosking DJ; Cassidy MJ Osteoporos Int; 2005 Feb; 16(2):142-8. PubMed ID: 15258722 [TBL] [Abstract][Full Text] [Related]
37. Bone mineral density and fracture rate in response to intravenous and oral bisphosphonates in adult osteogenesis imperfecta. Shapiro JR; Thompson CB; Wu Y; Nunes M; Gillen C Calcif Tissue Int; 2010 Aug; 87(2):120-9. PubMed ID: 20544187 [TBL] [Abstract][Full Text] [Related]
38. Initiation of Monthly Minodronate Therapy at an Early Stage After Hip Fracture. Ohishi T; Fujita T; Suzuki D; Nishida T; Okabayashi R; Yamamoto K; Ushirozako H; Banno T; Matsuyama Y J Clin Densitom; 2016; 19(3):352-8. PubMed ID: 27067298 [TBL] [Abstract][Full Text] [Related]
39. Prevention of bone loss and fracture after lung transplantation: a pilot study. Cahill BC; O'Rourke MK; Parker S; Stringham JC; Karwande SV; Knecht TP Transplantation; 2001 Oct; 72(7):1251-5. PubMed ID: 11602851 [TBL] [Abstract][Full Text] [Related]
40. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study. Shane E; Rodino MA; McMahon DJ; Addesso V; Staron RB; Seibel MJ; Mancini D; Michler RE; Lo SH J Heart Lung Transplant; 1998 Nov; 17(11):1089-96. PubMed ID: 9855448 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]